Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risks and Benefits of Radiofrequency Ablation for Chronic Venous Insufficiency (CEAP C3-C6) in Patients Aged 80 and Over: A Prospective Single-Arm Cohort Study

NCT07233616 is registered in ClinicalTrials.gov with Chengdu University of Traditional Chinese Medicine as lead sponsor.

NCT NCT07233616
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07233616 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risks and Benefits of Radiofrequency Ablation for Chronic Venous Insufficiency (CEAP C3-C6) in Patients Aged 80 and Over: A Prospective Single-Arm Cohort Study
Lead sponsor
Chengdu University of Traditional Chinese Medicine
Phase
Observational
Overall status
Recruiting
Start date
October 1, 2025
Completion date
September 1, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic venous insufficiency, cvi, cohort study, octogenarians(aged 80 and over), radiofrequency ablation